Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-11 Sale | 2024-07-12 5:15 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 5,000 | $12.26 | $61,300 | 878,311 (Indirect Direct) | View |
| 2024-06-28 Sale | 2024-07-02 5:30 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 20,000 | $10.77 | $215,400 | 883,311 (Indirect Direct) | View |
| 2024-06-04 Sale | 2024-06-06 5:01 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 1,175,000 | $14.85 | $17,448,750 | 708,114 (Indirect) | View |
| 2024-05-31 Sale | 2024-06-04 9:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 25,000 | $10.3 | $257,450 | 903,311 (Indirect Direct) | View |
| 2024-05-06 Sale | 2024-05-07 5:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 5,000 | $10.92 | $54,600 | 928,311 (Indirect Direct) | View |
| 2024-04-30 Sale | 2024-05-02 5:09 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 15,000 | $9.51 | $142,650 | 933,311 (Indirect Direct) | View |
| 2024-03-28 Sale | 2024-03-29 5:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 20,000 | $10.97 | $219,400 | 948,311 (Indirect Direct) | View |
| 2024-02-29 Sale | 2024-03-04 5:30 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 25,000 | $12.41 | $310,309 | 968,311 (Indirect Direct) | View |
| 2024-01-31 Sale | 2024-02-02 5:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 30,000 | $12.79 | $383,550 | 993,311 (Indirect Direct) | View |
| 2023-12-29 Sale | 2024-01-02 5:30 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 25,000 | $13.38 | $334,500 | 1,023,311 (Indirect Direct) | View |
| 2023-09-12 Purchase | 2023-12-18 6:30 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 640,000 | $10.74 | $6,871,279 | 4,383,875 (Indirect) | View |
| 2023-12-06 Purchase | 2023-12-08 4:19 pm | Olema Pharmaceuticals Inc. | OLMA | Paradigm Biocapital Advisors LP Paradigm BioCapital Advisors GP LLC Paradigm BioCapital International Fund Ltd. Asefaw Senai 10% Owner | 100,000 | $11.6 | $1,160,000 | 7,903,600 (Indirect) | View |
| 2023-11-30 Sale | 2023-12-01 5:15 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 25,000 | $12.57 | $314,250 | 1,048,311 (Indirect Direct) | View |
| 2023-11-21 Sale | 2023-11-22 7:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 8,181 | $14.39 | $117,740 | 1,073,311 (Indirect Direct) | View |
| 2023-11-21 Sale | 2023-11-22 7:00 pm | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 14,556 | $14.38 | $209,296 | 30,664 (Direct) | View |
| 2023-11-21 Sale | 2023-11-22 7:00 pm | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 13,629 | $14.4 | $196,233 | 741,776 (Indirect Direct) | View |
| 2023-11-21 Sale | 2023-11-22 7:00 pm | Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO | 57,225 | $14.4 | $824,134 | 144,925 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-14 Option Award | 2024-06-18 5:31 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner | 23,000 | $0 | 9,049,293 (Indirect) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Horning Sandra Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Hrustanovic Gorjan Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | CLARK IAN T Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Garland J. Scott Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | BUTITTA CYNTHIA M Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-05-24 Exercise | 2024-05-28 5:00 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 9,460 | $4.87 | 216,664 (Direct) | View |
| 2024-05-24 Exercise | 2024-05-28 5:00 pm | N/A 2033-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 9,460 | $0 | 216,664 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-20 5:30 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 13,700 | $4.87 | 216,664 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-20 5:30 pm | N/A 2033-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 13,700 | $0 | 216,664 (Direct) | View |
| 2024-03-05 Other | 2024-03-06 5:36 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director | 866,979 | $0 | 1,252,944 (Indirect) | View |
| 2024-02-01 Option Award | 2024-02-05 5:30 pm | N/A 2034-01-31 | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 195,000 | $0 | 195,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 5:30 pm | N/A 2034-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 195,000 | $0 | 195,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 5:30 pm | N/A 2034-01-31 | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 304,500 | $0 | 304,500 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 5:30 pm | N/A 2034-01-31 | Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO | 621,500 | $0 | 621,500 (Direct) | View |
| 2024-01-25 Exercise | 2024-01-29 07:30 am | N/A 2032-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 20,000 | $0 | 280,664 (Direct) | View |
| 2024-01-25 Exercise | 2024-01-29 07:30 am | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 20,000 | $7.02 | 280,664 (Direct) | View |
| 2024-01-12 Exercise | 2024-01-16 07:30 am | N/A 2032-01-31 | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 50,000 | $0 | 671,987 (Direct) | View |
| 2024-01-12 Exercise | 2024-01-16 07:30 am | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 50,000 | $7.02 | 671,987 (Direct) | View |
| 2023-12-12 Exercise | 2023-12-12 5:55 pm | N/A 2032-01-31 | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 10,000 | $0 | 671,987 (Direct) | View |
| 2023-12-12 Exercise | 2023-12-12 5:55 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 10,000 | $7.02 | 671,987 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-12 5:55 pm | N/A 2032-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 2,900 | $0 | 280,664 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-12 5:55 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 2,900 | $7.02 | 280,664 (Direct) | View |
| 2023-12-06 Exercise | 2023-12-07 8:30 pm | N/A 2032-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 13,100 | $0 | 280,664 (Direct) | View |
| 2023-12-06 Exercise | 2023-12-07 8:30 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 13,100 | $7.02 | 280,664 (Direct) | View |
| 2023-11-20 Option Award | 2023-11-22 7:00 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 15,750 | $0 | 1,073,311 (Direct) | View |
| 2023-11-20 Option Award | 2023-11-22 7:00 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 28,000 | $0 | 30,664 (Direct) | View |
| 2023-11-20 Option Award | 2023-11-22 7:00 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 26,250 | $0 | 741,776 (Direct) | View |
| 2023-11-20 Option Award | 2023-11-22 7:00 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO | 110,250 | $0 | 144,925 (Direct) | View |